Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2470709485', 'doi': 'https://doi.org/10.1097/wnf.0000000000000172', 'title': 'Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach', 'display_name': 'Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach', 'publication_year': 2016, 'publication_date': '2016-09-01', 'ids': {'openalex': 'https://openalex.org/W2470709485', 'doi': 'https://doi.org/10.1097/wnf.0000000000000172', 'mag': '2470709485', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27428884', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5026556'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/wnf.0000000000000172', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3349026', 'display_name': 'Clinical Neuropharmacology', 'issn_l': '0362-5664', 'issn': ['0362-5664', '1537-162X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://europepmc.org/articles/pmc5026556?pdf=render', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067695269', 'display_name': 'Rachel G. Greenberg', 'orcid': 'https://orcid.org/0000-0003-4156-8543'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Rachel G. Greenberg', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054954452', 'display_name': 'Chiara Melloni', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Chiara Melloni', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I4210088741']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046595721', 'display_name': 'Huali Wu', 'orcid': 'https://orcid.org/0000-0001-6767-5529'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Huali Wu', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075015951', 'display_name': 'Daniel González', 'orcid': 'https://orcid.org/0000-0001-5522-5686'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel Gonzalez', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078015097', 'display_name': 'Lawrence Ku', 'orcid': 'https://orcid.org/0000-0001-6201-7092'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Lawrence Ku', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055426845', 'display_name': 'Kevin D. Hill', 'orcid': 'https://orcid.org/0000-0003-4451-3580'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Kevin D. Hill', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085031950', 'display_name': 'Christoph P. Hornik', 'orcid': 'https://orcid.org/0000-0001-7056-8759'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Christoph P. Hornik', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021225091', 'display_name': 'Michael Cohen‐Wolkowiez', 'orcid': 'https://orcid.org/0000-0002-2458-2266'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Michael Cohen-Wolkowiez', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I4210088741']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049165680', 'display_name': 'Jeffrey T. Guptill', 'orcid': 'https://orcid.org/0000-0002-0312-0716'}, 'institutions': [{'id': 'https://openalex.org/I4210088741', 'display_name': 'Clinical Research Institute', 'ror': 'https://ror.org/009ywjj88', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210088741']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Jeffrey T. Guptill', 'raw_affiliation_strings': ['*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.'], 'affiliations': [{'raw_affiliation_string': '*Duke Clinical Research Institute, Durham; †Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and Office of Generic Drugs, US Food and Drug Administration, Silver Spring, MD.', 'institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5067695269', 'https://openalex.org/A5054954452', 'https://openalex.org/A5046595721', 'https://openalex.org/A5078015097', 'https://openalex.org/A5055426845', 'https://openalex.org/A5085031950', 'https://openalex.org/A5021225091', 'https://openalex.org/A5049165680'], 'corresponding_institution_ids': ['https://openalex.org/I4210088741', 'https://openalex.org/I1320320070', 'https://openalex.org/I1320320070', 'https://openalex.org/I4210088741', 'https://openalex.org/I4210088741', 'https://openalex.org/I1320320070', 'https://openalex.org/I4210088741', 'https://openalex.org/I1320320070', 'https://openalex.org/I4210088741', 'https://openalex.org/I1320320070', 'https://openalex.org/I4210088741', 'https://openalex.org/I1320320070', 'https://openalex.org/I1320320070', 'https://openalex.org/I4210088741', 'https://openalex.org/I4210088741', 'https://openalex.org/I1320320070'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.608, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 59, 'citation_normalized_percentile': {'value': 0.686713, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '39', 'issue': '5', 'first_page': '232', 'last_page': '240'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12229', 'display_name': 'Prenatal Exposure to Antiepileptic Drugs', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12229', 'display_name': 'Prenatal Exposure to Antiepileptic Drugs', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy and Seizures', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11943', 'display_name': 'Adverse Drug Reactions and Pharmacovigilance', 'score': 0.9941, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/therapeutic-index', 'display_name': 'Therapeutic index', 'score': 0.9290238}, {'id': 'https://openalex.org/keywords/phenobarbital', 'display_name': 'Phenobarbital', 'score': 0.7331055}, {'id': 'https://openalex.org/keywords/therapeutic-drug-monitoring', 'display_name': 'Therapeutic drug monitoring', 'score': 0.7305329}, {'id': 'https://openalex.org/keywords/antiepileptic-drugs', 'display_name': 'Antiepileptic Drugs', 'score': 0.603374}, {'id': 'https://openalex.org/keywords/therapeutic-effect', 'display_name': 'Therapeutic effect', 'score': 0.591729}], 'concepts': [{'id': 'https://openalex.org/C19831878', 'wikidata': 'https://www.wikidata.org/wiki/Q659446', 'display_name': 'Therapeutic index', 'level': 3, 'score': 0.9290238}, {'id': 'https://openalex.org/C2779253243', 'wikidata': 'https://www.wikidata.org/wiki/Q410412', 'display_name': 'Carbamazepine', 'level': 3, 'score': 0.8331932}, {'id': 'https://openalex.org/C2778802184', 'wikidata': 'https://www.wikidata.org/wiki/Q410346', 'display_name': 'Lamotrigine', 'level': 3, 'score': 0.798733}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7677419}, {'id': 'https://openalex.org/C2778337148', 'wikidata': 'https://www.wikidata.org/wiki/Q410400', 'display_name': 'Phenytoin', 'level': 3, 'score': 0.75352705}, {'id': 'https://openalex.org/C2778793413', 'wikidata': 'https://www.wikidata.org/wiki/Q407241', 'display_name': 'Phenobarbital', 'level': 2, 'score': 0.7331055}, {'id': 'https://openalex.org/C2780272996', 'wikidata': 'https://www.wikidata.org/wiki/Q1261151', 'display_name': 'Therapeutic drug monitoring', 'level': 3, 'score': 0.7305329}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.5937576}, {'id': 'https://openalex.org/C102652120', 'wikidata': 'https://www.wikidata.org/wiki/Q2419430', 'display_name': 'Therapeutic effect', 'level': 2, 'score': 0.591729}, {'id': 'https://openalex.org/C2778186239', 'wikidata': 'https://www.wikidata.org/wiki/Q41571', 'display_name': 'Epilepsy', 'level': 2, 'score': 0.5001719}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4894942}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.46109855}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.07102981}], 'mesh': [{'descriptor_ui': 'D000927', 'descriptor_name': 'Anticonvulsants', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016903', 'descriptor_name': 'Drug Monitoring', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D004827', 'descriptor_name': 'Epilepsy', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D016206', 'descriptor_name': 'Databases, Bibliographic', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 5, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/wnf.0000000000000172', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3349026', 'display_name': 'Clinical Neuropharmacology', 'issn_l': '0362-5664', 'issn': ['0362-5664', '1537-162X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5026556', 'pdf_url': 'https://europepmc.org/articles/pmc5026556?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026556', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.17615/kyqc-j152', 'pdf_url': 'https://cdr.lib.unc.edu/downloads/zk51vn87w', 'source': {'id': 'https://openalex.org/S4306401075', 'display_name': 'Carolina Digital Repository (University of North Carolina at Chapel Hill)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I114027177', 'host_organization_name': 'University of North Carolina at Chapel Hill', 'host_organization_lineage': ['https://openalex.org/I114027177'], 'host_organization_lineage_names': ['University of North Carolina at Chapel Hill'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27428884', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5026556', 'pdf_url': 'https://europepmc.org/articles/pmc5026556?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 80, 'referenced_works': ['https://openalex.org/W1599565459', 'https://openalex.org/W1917616782', 'https://openalex.org/W1965665318', 'https://openalex.org/W1967132667', 'https://openalex.org/W1967156918', 'https://openalex.org/W1971954813', 'https://openalex.org/W1972760125', 'https://openalex.org/W1973691008', 'https://openalex.org/W1973888618', 'https://openalex.org/W1975004386', 'https://openalex.org/W1978139201', 'https://openalex.org/W1983175184', 'https://openalex.org/W1988765602', 'https://openalex.org/W1989340210', 'https://openalex.org/W1989801730', 'https://openalex.org/W1990148301', 'https://openalex.org/W1990217557', 'https://openalex.org/W1994457839', 'https://openalex.org/W1995152416', 'https://openalex.org/W2002407252', 'https://openalex.org/W2002771915', 'https://openalex.org/W2005747088', 'https://openalex.org/W2006070766', 'https://openalex.org/W2007097633', 'https://openalex.org/W2008767312', 'https://openalex.org/W2014996233', 'https://openalex.org/W2027242474', 'https://openalex.org/W2031707513', 'https://openalex.org/W2032571712', 'https://openalex.org/W2032677433', 'https://openalex.org/W2036467957', 'https://openalex.org/W2037222801', 'https://openalex.org/W2039674635', 'https://openalex.org/W2042150102', 'https://openalex.org/W2044839799', 'https://openalex.org/W2048746782', 'https://openalex.org/W2049026746', 'https://openalex.org/W2057029335', 'https://openalex.org/W2058985568', 'https://openalex.org/W2060227584', 'https://openalex.org/W2064713139', 'https://openalex.org/W2065158147', 'https://openalex.org/W2068290827', 'https://openalex.org/W2070579660', 'https://openalex.org/W2071290527', 'https://openalex.org/W2071631995', 'https://openalex.org/W2075552514', 'https://openalex.org/W2076458078', 'https://openalex.org/W2076704776', 'https://openalex.org/W2082501248', 'https://openalex.org/W2082892977', 'https://openalex.org/W2085797913', 'https://openalex.org/W2090562151', 'https://openalex.org/W2092013975', 'https://openalex.org/W2094028846', 'https://openalex.org/W2094462303', 'https://openalex.org/W2095558066', 'https://openalex.org/W2103512719', 'https://openalex.org/W2106704593', 'https://openalex.org/W2113684969', 'https://openalex.org/W2118664099', 'https://openalex.org/W2125083151', 'https://openalex.org/W2132785864', 'https://openalex.org/W2136467310', 'https://openalex.org/W2137645809', 'https://openalex.org/W2138521331', 'https://openalex.org/W2140066702', 'https://openalex.org/W2144334446', 'https://openalex.org/W2145644724', 'https://openalex.org/W2146770720', 'https://openalex.org/W2147974822', 'https://openalex.org/W2154580853', 'https://openalex.org/W2162748306', 'https://openalex.org/W2166861535', 'https://openalex.org/W2265770402', 'https://openalex.org/W2320058521', 'https://openalex.org/W2322086287', 'https://openalex.org/W2331044904', 'https://openalex.org/W2416443525', 'https://openalex.org/W4319705831'], 'related_works': ['https://openalex.org/W4366071455', 'https://openalex.org/W2996746057', 'https://openalex.org/W2681294209', 'https://openalex.org/W2423350955', 'https://openalex.org/W2322833765', 'https://openalex.org/W2112021888', 'https://openalex.org/W2076024851', 'https://openalex.org/W2005840484', 'https://openalex.org/W1998692538', 'https://openalex.org/W1967132667'], 'abstract_inverted_index': {'Objectives': [0], 'Our': [1, 182], 'study': [2], 'aimed': [3], 'to': [4, 16, 42, 115, 158], 'determine': [5], 'whether': [6], 'data': [7, 50, 131, 157, 188], 'obtained': [8], 'from': [9, 132], 'the': [10, 18, 108, 111, 116, 138, 161], 'medical': [11], 'literature': [12, 36, 135], 'can': [13, 184], 'be': [14], 'used': [15], 'estimate': [17], 'therapeutic': [19, 48, 99, 105, 139, 146, 162, 179, 205], 'index': [20, 106, 140, 180, 206], 'of': [21, 76, 83, 110, 125, 141, 148, 164, 178], '5': [22, 52], 'antiepileptic': [23], 'drugs': [24], '(AEDs):': [25], 'carbamazepine,': [26], 'lamotrigine,': [27], 'phenobarbital,': [28], 'phenytoin,': [29], 'and': [30, 40, 47, 54, 62, 74, 80, 93, 97, 129, 150, 166, 192, 198], 'valproate.': [31], 'Methods': [32], 'We': [33, 103, 121], 'performed': [34], 'a': [35, 60, 123, 175], 'search': [37], 'using': [38], 'PubMed': [39], 'EMBASE': [41], 'collect': [43], 'published': [44], 'safety,': [45], 'efficacy,': [46], 'monitoring': [49, 101], 'for': [51, 189, 195], 'AEDs': [53], 'extracted': [55, 130], 'all': [56], 'relevant': [57], 'information': [58], 'into': [59], 'drug-': [61], 'study-specific': [63], 'drug': [64, 84, 100], 'database.': [65], 'For': [66, 169], 'each': [67], 'AED,': [68], 'we': [69], 'summarized': [70], '(1)': [71], 'type,': [72], 'severity,': [73], 'incidence': [75], 'toxicity-related': [77], 'adverse': [78], 'events': [79], 'toxicity-associated': [81], 'range': [82], 'doses': [85], 'or': [86], 'concentrations;': [87], '(2)': [88], 'effective': [89, 118], 'versus': [90], 'toxic': [91, 113], 'concentration': [92, 114], 'dose': [94], '(therapeutic': [95], 'range);': [96], '(3)': [98], 'practices.': [102], 'defined': [104], 'as': [107, 186, 193], 'ratio': [109], 'minimum': [112, 117], 'concentration.': [119], 'Results': [120], 'reviewed': [122], 'total': [124], '810': [126], 'full-text': [127], 'articles': [128], '163.': [133], 'The': [134, 145], 'suggests': [136], 'that': [137], 'phenytoin': [142], 'is': [143], '2.': [144, 153], 'indices': [147, 163], 'phenobarbital': [149], 'valproate': [151], 'exceed': [152], 'There': [154], 'were': [155], 'insufficient': [156], 'precisely': [159], 'quantify': [160], 'carbamazepine': [165], 'lamotrigine.': [167], 'Conclusions': [168], 'some': [170], 'drugs,': [171], 'this': [172], 'approach': [173], 'offers': [174], 'low-cost': [176], 'method': [177], 'estimation.': [181], 'results': [183], 'serve': [185], 'preliminary': [187], 'future': [190], 'trials': [191], 'guidance': [194], 'US': [196], 'Food': [197], 'Drug': [199], 'Administration': [200], 'decision': [201], 'making': [202], 'regarding': [203], 'narrow': [204], 'classification.': [207]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2470709485', 'counts_by_year': [{'year': 2024, 'cited_by_count': 11}, {'year': 2023, 'cited_by_count': 11}, {'year': 2022, 'cited_by_count': 8}, {'year': 2021, 'cited_by_count': 12}, {'year': 2020, 'cited_by_count': 6}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 2}], 'updated_date': '2024-09-13T12:44:08.220720', 'created_date': '2016-07-22'}